Prescient Therapeutics LimitedASX: PTX

First Cohort Successfully Completed in Phase 1b/2 AML Trial

Mar 8, 2017 at 4:22 AM UTC · Issued by Prescient Therapeutics Limited

Prescient Therapeutics Ltd has released a press release.

View Attachment